You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 10, 2024

Patent: 9,890,147

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,890,147

Title:	2,3-benzodiazepines
Abstract:	What is described are BET protein-inhibitory, in particular BRD4-inhibitory 2,3-benzodiazepines of the general formula (I) ##STR00001## in which R.sup.1a, R.sup.1b, R.sup.1c, R.sup.2, R.sup.3, R.sup.4, R.sup.5, A and X have the meanings given in the description, intermediates for preparing the compounds according to the invention, pharmaceutical compositions comprising the compounds according to the invention and their prophylactic and therapeutic use for hyperproliferative disorders, in particular for tumor disorders. Also described is the use of BET protein inhibitors for benign hyperplasias, atherosclerotic disorders, sepsis, autoimmune disorders, vascular disorders, viral infections, for neurodegenerative disorders, for inflammatory disorders, for atherosclerotic disorders and for the control of male fertility.
Inventor(s):	Siegel; Stephan (Berlin, DE), Baurle; Stefan (Berlin, DE), Cleve; Arwed (Berlin, DE), Haendler; Bernard (Berlin, DE), Fernandez-Montalvan; Amaury Ernesto (Berlin, DE), Monning; Ursula (Woltersdorf, DE), Krause; Sabine (Berlin, DE), Lejeune; Pascale (Berlin, DE), Schmees; Norbert (Berlin, DE), Busemann; Matthias (Berlin, DE), Holton; Simon (Berlin, DE), Kuhnke; Joachim (Potsdam, DE)
Assignee:	Bayer Pharma Aktiengesellshaft (Berlin, DE)
Application Number:	14/421,994
Patent Claims:	see list of patent claims

Details for Patent 9,890,147

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978	⤷ Try a Trial	2032-08-16
Amgen, Inc.	EPOGEN/PROCRIT	epoetin alfa	Injection	103234	06/01/1989	⤷ Try a Trial	2032-08-16
Amgen, Inc.	EPOGEN/PROCRIT	epoetin alfa	Injection	103234		⤷ Try a Trial	2032-08-16
Amgen, Inc.	PROCRIT	epoetin alfa	Injection	103234		⤷ Try a Trial	2032-08-16
Clinigen, Inc.	PROLEUKIN	aldesleukin	For Injection	103293	05/05/1992	⤷ Try a Trial	2032-08-16
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.